International Updates

Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Articles

Ireland opens up their first medical cannabis clinic.

Medicann Pioneers Ireland's First Comprehensive Medical Cannabis Clinic, Expanding Access and Treatment Options

The recent statement highlighted a lack of research, provides recommendations, and called for unbiased education for clinicians.

 Canadian Paediatric Society Publishes Recommendations on Medical Cannabis Use in Children

To help the mental health of citizens and soldiers, the president of Ukraine called for more support for medical cannabis legalization in the country.

Ukraine President Calls for Medical Cannabis Legalization to Address Mental Health Challenges

As part of a plan to double its GDP and create more job opportunities, the Isle of Man is looking to grow and export cannabis products for medical use.

A British Island Territory Plans to License Medical Cannabis to Expand Economy and Boost Population Growth

The Nova Scotia House of Assembly recently heard a petition to cover the cost of CBD-based medications for certain conditions.

Petition Calls on Nova Scotia Government to Cover Cost of Cannabidiol-Based Medications for Children with Life-Threatening Diseases

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.

One Case Study Shows How a Woman in the UK Reduced her Prescription Pain Medication With Cannabis

Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.

Cannabidiol for Potentially Treating Psychosis: International Study Launched by University of Oxford

Cannabidiol (CBD) was recently studied in Mexico as a treatment for traumatic brain injury and Parkinson’s Disease.

Recent Studies from Medical Marijuana Inc. Test Cannabidiol for Treatment of Two Conditions

Starting July 1, 2023, Australia will allow the use of psilocybin and 3,4-Methylenedioxymethamphetamine (MDMA) for therapeutic use in a medical setting to treat mental health conditions.

Australia to Reschedule Psilocybin and MDMA for Therapeutic Use Starting in July 2023

A farmer in Ireland who was arrested for growing and selling cannabis from his farm received a suspended sentence. Currently, cannabis is illegal in Ireland, except within a limited medical program.